Bionano Genomics, Inc.
BNGO
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kitsā¦ read more
Healthcare
Diagnostics & Research
7 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$1.07
Price+0.94%
$0.01
1Y
Price
Market Cap
$12.278m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-87.6%
EBITDA Margin-124.2%
Net Profit Margin-85.5%
Free Cash Flow Margin-87.6%
EBITDA Margin-124.2%
Net Profit Margin-85.5%
Free Cash Flow MarginRevenue
$28.738m
+0.8%
1y CAGR-7.1%
3y CAGR+2.1%
5y CAGREarnings
-$31.596m
-19.7%
1y CAGR+36.2%
3y CAGR+8.3%
5y CAGREPS
-$5.80
-19.6%
1y CAGR+51.1%
3y CAGR+25.2%
5y CAGRBook Value
$37.463m
$64.804m
Assets$27.341m
Liabilities$17.014m
DebtDebt to Assets
26.3%
-0.8x
Debt to EBITDAFree Cash Flow
-$19.297m
-18.1%
1y CAGR+34.6%
3y CAGR+26.2%
5y CAGRNo items found.
Press Releases
Statements and updates from the company